CelLBxHealth Insider Confidence Rewarded, Stock Hits UK£24m Market Cap

Last week, CelLBxHealth plc (LON:CLBX) insiders, who had purchased shares in the previous 12 months were rewarded handsomely. The shares increased by 23% last week, resulting in a UK£4.5m increase in the company’s market worth, implying a 115% gain on their initial purchase. In other words, the original UK£125.0k purchase is now worth UK£268.8k.

While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we do think it is perfectly logical to keep tabs on what insiders are doing.

Trump has pledged to “unleash” American oil and gas and these 15 US stocks have developments that are poised to benefit.

CelLBxHealth Insider Transactions Over The Last Year

The Executive Chairman Jan Groen made the biggest insider purchase in the last 12 months. That single transaction was for UK£50k worth of shares at a price of UK£0.01 each. Even though the purchase was made at a significantly lower price than the recent price (UK£0.021), we still think insider buying is a positive. Because it occurred at a lower valuation, it doesn’t tell us much about whether insiders might find today’s price attractive.

CelLBxHealth insiders may have bought shares in the last year, but they didn’t sell any. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

See our latest analysis for CelLBxHealth

CelLBxHealth is not the only stock that insiders are buying. For those who like to find small cap companies at attractive valuations, this free list of growing companies with recent insider purchasing, could be just the ticket.

Does CelLBxHealth Boast High Insider Ownership?

Many investors like to check how much of a company is owned by insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. It appears that CelLBxHealth insiders own 17% of the company, worth about UK£4.1m. While this is a strong but not outstanding level of insider ownership, it’s enough to indicate some alignment between management and smaller shareholders.

So What Do The CelLBxHealth Insider Transactions Indicate?

It doesn’t really mean much that no insider has traded CelLBxHealth shares in the last quarter. But insiders have shown more of an appetite for the stock, over the last year. Insiders do have a stake in CelLBxHealth and their transactions don’t cause us concern. In addition to knowing about insider transactions going on, it’s beneficial to identify the risks facing CelLBxHealth. Be aware that CelLBxHealth is showing 6 warning signs in our investment analysis, and 2 of those can’t be ignored…

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.